Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jason Harmon Wasfy, M.D.

Co-Author

This page shows the publications co-authored by Jason Wasfy and Cian McCarthy.
Connection Strength

7.307
  1. McCarthy CP, Murphy S, Jones-O'Connor M, Olshan DS, Khambhati JR, Rehman S, Cadigan JB, Cui J, Meyerowitz EA, Philippides G, Friedman LS, Kadar AY, Hibbert K, Natarajan P, Massaro AF, Bohula EA, Morrow DA, Woolley AE, Januzzi JL, Wasfy JH. Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system. EClinicalMedicine. 2020 Sep; 26:100504.
    View in: PubMed
    Score: 0.983
  2. McCarthy CP, Murphy S, Rehman S, Jones-O'Connor M, Olshan DS, Cohen JA, Cui J, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Home-Time After Discharge Among Patients With Type 2 Myocardial Infarction. J Am Heart Assoc. 2020 May 18; 9(10):e015978.
    View in: PubMed
    Score: 0.964
  3. McCarthy CP, McWalters ST, Wasfy JH. ICD-10 Coding of Type 2 Myocardial Infarction and Myocardial Injury as It Relates to US Centers for Medicare & Medicaid Services Value-Based Payment Programs-Reply. JAMA Cardiol. 2019 10 01; 4(10):1051-1052.
    View in: PubMed
    Score: 0.925
  4. McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Sex Differences in Patient Characteristics, Treatment Strategies, and Outcomes for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2019 06 25; 73(24):3230-3232.
    View in: PubMed
    Score: 0.908
  5. McCarthy C, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs. JAMA Cardiol. 2019 05 01; 4(5):460-464.
    View in: PubMed
    Score: 0.898
  6. McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL, Wasfy JH. Underutilization of Cardiac Rehabilitation for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2019 04 23; 73(15):2005-2007.
    View in: PubMed
    Score: 0.888
  7. McCarthy CP, Bhambhani V, Pomerantsev E, Wasfy JH. In-hospital outcomes in invasively managed acute myocardial infarction patients who receive morphine. J Interv Cardiol. 2018 Apr; 31(2):150-158.
    View in: PubMed
    Score: 0.813
  8. Murphy SP, McCarthy CP, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Cui J, Januzzi JL, Wasfy JH. Application of the GRACE, TIMI, and TARRACO Risk Scores in Type 2 Myocardial Infarction. J Am Coll Cardiol. 2020 01 28; 75(3):344-345.
    View in: PubMed
    Score: 0.233
  9. Raber I, McCarthy CP, Wasfy JH. Integrating Inpatient Electronic Consultations in Cardiology Fellowship. J Am Coll Cardiol. 2019 08 27; 74(8):1151-1155.
    View in: PubMed
    Score: 0.230
  10. McCarthy CP, Vaduganathan M, Singh A, Song Z, Blankstein R, Gaggin HK, Wasfy JH, Januzzi JL. Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program. J Am Coll Cardiol. 2018 09 04; 72(10):1166-1170.
    View in: PubMed
    Score: 0.215
  11. McCarthy CP, Donnellan E, Wasfy JH, Bhatt DL, McEvoy JW. Time-honored treatments for the initial management of acute coronary syndromes: Challenging the status quo. Trends Cardiovasc Med. 2017 10; 27(7):483-491.
    View in: PubMed
    Score: 0.196
  12. Vidula MK, McCarthy CP, Butala NM, Kennedy KF, Wasfy JH, Yeh RW, Secemsky EA. Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy. PLoS One. 2018; 13(10):e0205457.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.